Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases

Konstantinos Papamichael(Beth Israel Deaconess Medical Center), Adam S. Cheifetz(Beth Israel Deaconess Medical Center), Gil Melmed(Cedars-Sinai Medical Center), Peter M. Irving(St Thomas' Hospital), Niels Vande Casteele(University of California San Diego), Patricia Kozuch(Thomas Jefferson University), Laura E. Raffals(Mayo Clinic), Leonard Baidoo(Northwestern University), Brian Bressler(University of British Columbia), Shane Devlin(University of Calgary), Jennifer Jones(Dalhousie University), Gilaad G. Kaplan(University of Calgary), Miles Sparrow(The Alfred Hospital), Fernando Velayos(University of California, San Francisco), Thomas Ullman(Montefiore Medical Center), Corey A. Siegel(Dartmouth–Hitchcock Medical Center)
Clinical Gastroenterology and Hepatology
March 27, 2019
Cited by 326Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis